Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activities of streptomycin and 11 oral antimicrobial agents against clinical isolates of Klebsiella rhinoscleromatis.

Literature DB >> 1416867

In vitro activities of streptomycin and 11 oral antimicrobial agents against clinical isolates of Klebsiella rhinoscleromatis.

B A Perkins¹, R J Hamill, D M Musher, C O'Hara.

Abstract

We tested in vitro the activities of streptomycin and tetracycline--antibiotics that have long been used to treat rhinoscleroma--as well as several newer oral agents by using 23 isolates of the causative organism Klebsiella rhinoscleromatis. All isolates were inhibited by clinically achievable concentrations of trimethoprim-sulfamethoxazole, amoxicillin-clavulanate, chloramphenicol, ciprofloxacin, cephalexin, cefuroxime, and cefpodoxime.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 1992 PMID： 1416867 PMCID： PMC192049 DOI： 10.1128/AAC.36.8.1785

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

16 in total

1. The management of rhinoscleroma.

Authors: C L Ssali
Journal: J Laryngol Otol Date: 1975-01 Impact factor: 1.469

2. The biochemistry and an tribiotic sensitivity of the Klebsiellae.

Authors: S S EPSTEIN
Journal: J Clin Pathol Date: 1959-01 Impact factor: 3.411

3. Scleroma in Guatemala, with a study of the disease based on the experience of 108 cases.

Authors: J QUEVEDO
Journal: Ann Otol Rhinol Laryngol Date: 1949-09 Impact factor: 1.547

4. Problems of the epidemiology of scleroma. I. Geographical distribution of scleroma.

Authors: M M Muzyka; K M Gubina
Journal: J Hyg Epidemiol Microbiol Immunol Date: 1971

5. Klebsiella rhinoscleromatis: a clinical and pathogenic enigma.

Authors: R H Miller; J B Shulman; R F Canalis; P H Ward
Journal: Otolaryngol Head Neck Surg (1979) Date: 1979 Mar-Apr

6. Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria.

Authors: R Darouiche; B Perkins; D Musher; R Hamill; S Tsai
Journal: J Infect Dis Date: 1990-11 Impact factor: 5.226

In vitro activities of streptomycin and 11 oral antimicrobial agents against clinical isolates of Klebsiella rhinoscleromatis.

1. The management of rhinoscleroma.

2. The biochemistry and an tribiotic sensitivity of the Klebsiellae.

3. Scleroma in Guatemala, with a study of the disease based on the experience of 108 cases.

4. Problems of the epidemiology of scleroma. I. Geographical distribution of scleroma.

5. Klebsiella rhinoscleromatis: a clinical and pathogenic enigma.

6. Levels of rifampin and ciprofloxacin in nasal secretions: correlation with MIC90 and eradication of nasopharyngeal carriage of bacteria.

7. Rhinoscleroma.

8. Isolation of Klebsiella ozaenae and Klebsiella rhinoscleromatis in a general hospital.

9. IDENTIFICATION AND CLINICAL SIGNIFICANCE OF KLEBSIELLA SPECIES IN CHEST INFECTIONS.

10. Local rifampicin in treatment of rhinoscleroma.

1. Antimicrobial-resistant Klebsiella species isolated from free-range chicken samples in an informal settlement.

2. Rhinoscleroma with Pharyngolaryngeal Involvement Caused by Klebsiella ozaenae.